Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the antibody response and reaction rates in children age 6-23 months when they are given either the currently recommended schedule of two 0.25ml doses of influe...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
British Columbia Centre for Disease Control
NCT01386424 · Zika, Influenza
NCT07169318 · Influenza
NCT05648448 · Influenza, Influenza, Human
NCT07291635 · Influenza
NCT06599658 · COVID 19, Influenza, and more
Coquitlam, British Columbia
Vaccine Evaluation Centre
Vancouver, British Columbia
Dalhousie University / IWK Health Centre
Halifax, Nova Scotia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions